Suzhou MgPlus PharmTec Co., Ltd. was founded in 2021, is a fast growing contract research, contract development and manufacturing organization (CRO&CDMO). MgPlus PharmTec's core advantages are chemical drug small molecule compound synthetic process design, development and optimization, manufacturing of regulatory starting material and advanced intermediates from pre-clinical phase to commercial production. Click for details>>